The JAK/STAT pathway is a central pathogenic component in myelofibrosis seen in myeloproliferative neoplasm (MPN)33 and is largely due to the JAK2 V617F mutation, calreticulin mutation or c‐MPL mutation. Here, SOAT1 is linked to myeloproliferative disorder.